Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Appointed director
|
|
Fortress Biotech, Inc. (FBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
SC 13D/A
| Fortress Biotech, Inc. reports a 11.3% stake in CHECKPOINT THERAPEUTICS, INC. |
| 07/06/2023 |
SC 13D/A
| Fortress Biotech, Inc. reports a 13.6% stake in CHECKPOINT THERAPEUTICS, INC. |
| 04/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/13/2023 |
SC 13D/A
| Fortress Biotech, Inc. reports a 20.7% stake in MUSTANG BIO, INC. |
| 01/13/2023 |
SC 13D/A
| Fortress Biotech, Inc. reports a 19.3% stake in CHECKPOINT THERAPEUTICS, INC. |
| 01/06/2023 |
SC 13D/A
| Fortress Biotech, Inc. reports a 11.3% stake in AVENUE THERAPEUTICS, INC. |
| 05/17/2019 |
SC 13D/A
| Fortress Biotech, Inc. reports a 29.9% stake in MUSTANG BIO, INC. |
| 04/19/2019 |
SC 13D/A
| Fortress Biotech, Inc. reports a 31.9% stake in CHECKPOINT THERAPEUTICS, INC. |
| 04/19/2019 |
SC 13D/A
| Fortress Biotech, Inc. reports a 23.3% stake in AVENUE THERAPEUTICS, INC. |
| 04/19/2019 |
SC 13D/A
| Fortress Biotech, Inc. reports a 0% stake in National Holdings Corporation |
| 11/26/2018 |
SC 13D/A
| Fortress Biotech, Inc. reports a 32.1% stake in National Holdings Corporation |
| 01/27/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/27/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
|
|